Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies.
de Abreu, Paloma
Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies. [electronic resource] - Reumatologia clinica - 396-404 p. digital
Publication Type: Journal Article; Observational Study
2173-5743
10.1016/j.reuma.2018.08.009 doi
Adalimumab--adverse effects
Adult
Antibodies, Monoclonal, Humanized--adverse effects
Antirheumatic Agents--adverse effects
Arthritis, Juvenile--drug therapy
Arthritis, Rheumatoid--drug therapy
Biological Products--adverse effects
Female
Humans
Male
Middle Aged
Paraguay
Prospective Studies
Registries
Survival Rate
Uruguay
Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies. [electronic resource] - Reumatologia clinica - 396-404 p. digital
Publication Type: Journal Article; Observational Study
2173-5743
10.1016/j.reuma.2018.08.009 doi
Adalimumab--adverse effects
Adult
Antibodies, Monoclonal, Humanized--adverse effects
Antirheumatic Agents--adverse effects
Arthritis, Juvenile--drug therapy
Arthritis, Rheumatoid--drug therapy
Biological Products--adverse effects
Female
Humans
Male
Middle Aged
Paraguay
Prospective Studies
Registries
Survival Rate
Uruguay